Dhaka for sustainable trade ties with Colombo

Bangladesh wants to have a long-term and sustainable trade relations with Sri Lanka as part of its vision to boost trade with neighbours.

“Dhaka and Colombo are engaged in negotiations to sign a trade framework to increase two-way trade,” Bangladesh High Commissioner to Sri Lanka Sufiur Rahman told the Dhaka Tribune.

 Both the countries are conducting studies to see which will be better -a limited-scale preferential trade arrangement or broad-scale free trade agreement.

“After the completion of the studies, both the nations will negotiate to strike a deal.” At present, the total trade between Bangladesh and Sri Lanka is about $100m, which is almost balanced.

Citing from statistics, Sufiur said Bangladesh was enjoying more favourable conditions in the manufacturing sector than Sri Lanka.

The highest slab of commercial power tariff is around Tk8 in Bangladesh while it is over Tk40 in Sri Lanka, one of the highest in the world.

“Our mission pays 62 Sri Lankan Rupees for per unit power, which is equivalent to about Tk40,” he said.

The wage rate in Colombo is about three times higher than in Dhaka while the bank interest rate is on an average 17% in Sri Lanka compared to 15% in Bangladesh, the high commissioner said.

“But the advantage they (Sri Lanka) have is managerial efficiency and IT expertise.”

Sri Lanka and Pakistan signed free trade agreement (FTA) in 1999 and during the time Colombo’s export to Islamabad was around $30m, which now stood at above $150m.

Colombo and New Delhi signed FTA in 2000 when Sri Lanka exported $80m worth of products to India. But now it increased over six times to about $500m.

In both the cases, Sri Lanka was the weaker side meaning had less competitive advantage.

Bangladesh government also mulls another long-term deal for pharmaceutical products export to Sri Lanka.

Bangladesh exports pharmaceutical products worth of $79m currently to 80 countries with $6m to Sri Lanka.

“Sri Lanka imports about $380m of medicines every year mostly from India. If Bangladesh had grabbed 10-20% share of it, the pharmaceutical import to Sri Lanka would reach $40-80m,” Sufiur Rahman pointed out.

A Bangladeshi delegation led by health secretary will be visiting the South Asian nation in the third week this month and will negotiate to sign an agreement on long-term medicine supply.

“We have proposed if a Bangladeshi product is registered with USFDA or has a European registration, it should be eligible to export to Sri Lankan market without re-registration,” Sufi said.

If Sri Lankan side agrees with Bangladesh’s proposal, the deal is expected to be signed “very soon,” he hoped.